AEON Biopharma, Inc.
AEON
$0.88
$0.00-0.23%
AMEX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -37.14M | -4.54M | -6.64M | 9.10M | 2.08M |
| Total Depreciation and Amortization | 20.00K | 19.00K | 20.00K | 19.00K | 23.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 33.51M | 2.49M | 3.99M | -11.21M | -6.02M |
| Change in Net Operating Assets | -1.10M | -568.00K | 537.00K | -5.81M | 3.30M |
| Cash from Operations | -4.71M | -2.60M | -2.09M | -7.91M | -621.00K |
| Capital Expenditure | 0.00 | 0.00 | 0.00 | -4.00K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 0.00 | 0.00 | 0.00 | -4.00K | -- |
| Total Debt Issued | -- | -- | -- | -- | 0.00 |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00 | 84.00K | 84.00K | 18.35M | 97.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 1.79M | -- | -- | -- | -- |
| Cash from Financing | 1.79M | 84.00K | 84.00K | 18.35M | 97.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.92M | -2.51M | -2.01M | 10.43M | -524.00K |